EUVIMEDScopri EUVIMED
Crossref

Hybrid Conjugates of Ibuprofen and 3,5‐Diarylidene‐4‐Piperidone: A New Avenue in Anti‐Inflammatory Drug Discovery

Julio C Chavez, Adel S Girgis, Marian N Aziz, Shilpi Khurana, Brandon Carr, Guido F Verbeck, Siva S Panda

ChemMedChem · 2025

DOI: 10.1002/cmdc.202500342 ↗

At a glance

Journal article in ChemMedChem, 2025. Written by Julio C Chavez and 6 co-authors. Institution: Department of Chemistry and Biochemistry, Augusta University, Augusta, Georgia, 30912, USA. Major MEDLINE topics: Ibuprofen, Anti-Inflammatory Agents, Non-Steroidal. Cited 1 times so far (Crossref); 77 references. Funded by: National Research Centre, Egypt.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Nonsteroidal anti‐inflammatory drugs (NSAIDs) have been crucial in managing inflammation, pain, and fever since their introduction in 1897. Despite their widespread use, NSAIDs often face limitations due to gastrointestinal side effects from the nonselective inhibition of cyclooxygenase (COX) isoenzymes, COX‐1 and COX‐2. While selective COX‐2 inhibitors reduce gastrointestinal toxicity, they come with increased cardiovascular risks. This study investigates the synthesis and biological evaluation of novel hybrid NSAID conjugates incorporating 3,5‐diarylidene‐4‐piperidinone, ibuprofen, and amino acids. These hybrid molecules are designed to enhance anti‐inflammatory efficacy while minimizing adverse effects. The synthesized compounds are evaluated for COX inhibition and their effects on inflammatory mediators such as interleukin‐6, tumor necrosis factor‐alpha, and nitric oxide. Computational studies, including molecular docking and ADME (absorption, distribution, metabolism, and excretion) analyses, are performed to clarify the mechanisms of action and to predict pharmacokinetic properties. The findings indicate that some hybrid conjugates display promising anti‐inflammatory properties, necessitating further investigation for their potential therapeutic applications.

Subjects

MeSH terms (MEDLINE)

IbuprofenAnti-Inflammatory Agents, Non-SteroidalDrug DiscoveryTumor Necrosis Factor-alphaStructure-Activity RelationshipCyclooxygenase InhibitorsInterleukin-6Cyclooxygenase 1Cyclooxygenase 2HumansAnimals

Author keywords

3,5‐diarylidene‐4‐piperidoneanti‐inflammatorycyclooxygenaseibuprofenmolecular modeling

Substances

IbuprofenAnti-Inflammatory Agents, Non-SteroidalTumor Necrosis Factor-alphaCyclooxygenase InhibitorsInterleukin-6Cyclooxygenase 1Cyclooxygenase 2

Authors and institutions

  • Department of Chemistry and Biochemistry, Augusta University, Augusta, Georgia, 30912, USA.
  • Department of Pesticide Chemistry, National Research Centre, Dokki, Giza, 12622, Egypt.
  • Department of Chemistry, Deshbandhu College, University of Delhi, Delhi, 110019, India.
  • Department of Biochemistry and Molecular Biology, Augusta University, Augusta, Georgia, 30912, USA.

Funding

  • National Research Centre, Egypt

Cite

APA

Chavez, J. C., Girgis, A. S., Aziz, M. N., Khurana, S., Carr, B., Verbeck, G. F., & Panda, S. S. (2025). Hybrid Conjugates of Ibuprofen and 3,5‐Diarylidene‐4‐Piperidone: A New Avenue in Anti‐Inflammatory Drug Discovery. ChemMedChem. https://doi.org/10.1002/cmdc.202500342

Vancouver

Chavez JC, Girgis AS, Aziz MN, Khurana S, Carr B, Verbeck GF, et al. Hybrid Conjugates of Ibuprofen and 3,5‐Diarylidene‐4‐Piperidone: A New Avenue in Anti‐Inflammatory Drug Discovery. ChemMedChem. 2025. doi:10.1002/cmdc.202500342

BibTeX
@article{Chavez2025,
  author = {Chavez, Julio C and Girgis, Adel S and Aziz, Marian N and Khurana, Shilpi and Carr, Brandon and Verbeck, Guido F and Panda, Siva S},
  title = {Hybrid Conjugates of Ibuprofen and 3,5‐Diarylidene‐4‐Piperidone: A New Avenue in Anti‐Inflammatory Drug Discovery},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202500342}
}
Start for free →